Abstract: Embodiments of the present invention relate to a combination of experimental and computational workflows that allow characterization of skin and subcutaneous tissue microbial flora and its associated metabolome, aiming to first evaluate an individual's skin and subcutaneous tissue to determine if any skin condition is as a result of an imbalance or absence of commensal or mutualistic microorganisms or their associated metabolites. In particular, embodiments of the methods and the associated computational platform provided herein relate to conducting a customized or personalized test and obtaining customized or personalized information regarding the skin and subcutaneous tissue flora and its associated metabolome there from. This may be accomplished by simultaneously identifying hundreds of microorganisms or metabolites on an individual's skin and subcutaneous tissue and comparing the resulting profile to a previously compiled healthy profile from our database of skin profiles.

Abstract: The present invention relates to a combination of experimental and computational workflows that allow characterization of specific molecular mechanisms by which the microbiome contribute to skin health and skin age.

Abstract: The present invention relates to a combination of experimental and computational workflows that allow characterization of specific molecular mechanisms by which the microbiome contribute to skin health and skin age.

Abstract: Embodiments of the present invention relate to a combination of experimental and computational workflows that allow characterization of skin and subcutaneous tissue microbial flora and its associated metabolome, aiming to first evaluate an individual's skin and subcutaneous tissue to determine if any skin condition is as a result of an imbalance or absence of commensal or mutualistic microorganisms or their associated metabolites. In particular, embodiments of the methods and the associated computational platform provided herein relate to conducting a customized or personalized test and obtaining customized or personalized information regarding the skin and subcutaneous tissue flora and its associated metabolome there from. This may be accomplished by simultaneously identifying hundreds of microorganisms or metabolites on an individual's skin and subcutaneous tissue and comparing the resulting profile to a previously compiled healthy profile from our database of skin profiles.

Abstract: Disclosed herein are methods, systems, and media for monetizing health information to provide debt rehabilitation, which include: tools for an individual to create a profile, associate fitness data, genetic data, and medical data; an algorithm to generate a monetary market value for each profile; tools for allowing a health data consumer to search and browse the database of profiles, select one or more profiles, and enter into a license agreement for access to the selected profiles; and applications to manage collection of licensing fees associated with the license agreement from the health data consumer and distribution of the licensing fees to create a revenue stream.

Abstract: Present invention relate to a combination of experimental and computational workflows that allow characterization of skin and subcutaneous tissue microbial flora and its associated metabolome, aiming to first evaluate an individual's skin and subcutaneous tissue to determine if any skin condition is as a result of an imbalance or absence of commensal or mutualistic microorganisms or their associated metabolites. The methods and the associated computational platform provided herein relate to conducting a customized or personalized test and obtaining customized or personalized information regarding the skin and subcutaneous tissue flora and its associated metabolome there from also have been disclosed.

Abstract: The present invention relates to a combination of experimental and computational workflows that allow characterization of specific molecular mechanisms by which the microbiome contribute to skin health and skin age.

Abstract: The present invention relates to a combination of experimental and computational workflows that allow characterization of specific molecular mechanisms by which the microbiome contribute to skin health and skin age.

Abstract: Embodiments of the present invention relate to a combination of experimental and computational workflows that allow characterization of skin and subcutaneous tissue microbial flora and its associated metabolome, aiming to first evaluate an individual's skin and subcutaneous tissue to determine if any skin condition is as a result of an imbalance or absence of commensal or mutualistic microorganisms or their associated metabolites. In particular, embodiments of the methods and the associated computational platform provided herein relate to conducting a customized or personalized test and obtaining customized or personalized information regarding the skin and subcutaneous tissue flora and its associated metabolome there from. This may be accomplished by simultaneously identifying hundreds of microorganisms or metabolites on an individual's skin and subcutaneous tissue and comparing the resulting profile to a previously compiled healthy profile from our database of skin profiles.

Abstract: Disclosed herein are methods, systems, and media for managing health information that enable individuals to create a profile, associate fitness data, genetic data, and medical data and designate one or more recipient successors for all or part of their profile to create a health trust. Also disclosed herein are methods, systems, and media for providing a marketplace for health information by maintaining a database of profiles, each profile including personal information, fitness data, genetic data, and medical data for the individual, applying an algorithm to generate a monetary market value for each profile, enabling health data consumers to conduct a search of the database, and enabling the health data consumers to select identified profiles and subscribe to the selected profiles.

Abstract: Described herein are systems, methods, and compositions for treating a skin condition in an individual. A system or method is used to determine a skin flora of an individual and a sensitivity of the skin flora to a treatment modality. A composition is then customized based on the sensitivity of the skin flora to the treatment modality.

Abstract: Disclosed herein are methods, systems, and media for managing health information that enable individuals to create a profile, associate fitness data, genetic data, and medical data and designate one or more recipient successors for all or part of their profile to create a health trust. Also disclosed herein are methods, systems, and media for providing a marketplace for health information by maintaining a database of profiles, each profile including personal information, fitness data, genetic data, and medical data for the individual, applying an algorithm to generate a monetary market value for each profile, enabling health data consumers to conduct a search of the database, and enabling the health data consumers to select identified profiles and subscribe to the selected profiles.

Abstract: The present invention relates to a combination of experimental and computational workflows that allow characterization of specific molecular mechanisms by which the microbiome contribute to skin health and skin age.

Abstract: The present invention relates to providing a platform for predictive modeling of changes in composition of microbial communities upon exposure to changes or perturbations in the environment, more specifically the introduction of antimicrobial compounds, bacteriophages, or other agents that can be used for targeted or personalized therapy or microbiome remodeling. This platform has applications for human and animal health as well as environmental purposes.

Abstract: Present invention relate to a combination of experimental and computational workflows that allow characterization of skin and subcutaneous tissue microbial flora and its associated metabolome, aiming to first evaluate an individual's skin and subcutaneous tissue to determine if any skin condition is as a result of an imbalance or absence of commensal or mutualistic microorganisms or their associated metabolites. The methods and the associated computational platform provided herein relate to conducting a customized or personalized test and obtaining customized or personalized information regarding the skin and subcutaneous tissue flora and its associated metabolome there from also have been disclosed.

Abstract: Systems and processes are provided for securely storing, retrieving, sharing, and selling private data, such as genome wide sequences, sequence related metadata, electronic healthcare data, biological data, demographic data, medical data, and other biomedical data, which, in turn, may allow the usage of genomic variations at multiple scales and across multiple population strata. In some examples, users may be matched with healthcare experts based on a medical need or interest. In other examples, an information-based market for utilizing the available data in a privacy-preserving manner may be provided. In these examples, individual or group data may be tracked, compared, rated, analyzed, and priced to allow individuals to establish connections and/or carry out financial transactions using their data with other participants, healthcare practitioners, and businesses.